Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.
基于微流控技术的患者来源类器官重现了甲状腺癌的异质性,并揭示了 NF-κB 驱动的成熟过程,可用于精准治疗。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07882-z
Gao Hengyuan, Lin Junqing, Chen Xiaobing, Su Yingshi, Huang Yibin, Zhang Yubo, Zhang Junchang, Xu Nan, Dai Xiaoyong